 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              The Nomination and Remuneration / Compensation Committee of Aurobindo Pharma Ltd on March 09, 2016 has allotted 3,50,036 equity shares of Re.1/- each under ESOP Scheme of the Company. Consequent to the allotment, the paid up share capital of the Company has increased from 58,48,19,550 Equity Shares of Re.1/- each to 58,51,69,586 Equity Shares of Re.1/- each.
Shares of AUROBINDO PHARMA LTD. was last trading in BSE at Rs.716.6 as compared to the previous close of Rs. 705.25. The total number of shares traded during the day was 183190 in over 5506 trades.
The stock hit an intraday high of Rs. 720.4 and intraday low of 695. The net turnover during the day was Rs. 130406981.